We are live on ! Find out more
KXA

KPCB XV Associates Portfolio holdings

AUM $35.8M
1-Year Est. Return 57.59%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
-57.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$127M
AUM Growth
-$7.13M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 60.91%
2 Technology 39.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWLO icon
1
Twilio
TWLO
$28B
$49.5M 39.09%
188,160
RAPT
2
DELISTED
RAPT Therapeutics
RAPT
$47.6M 37.58%
162,133
ATRA icon
3
Atara Biotherapeutics
ATRA
$74.6M
$29.6M 23.33%
75,066

Similar funds

KPCB XV Associates's Q4 2021 Portfolio in Review

As of Q4 2021, KPCB XV Associates held 3 positions worth $127M, down 5.3% from $134M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 0%. KPCB XV Associates opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 55% a quarter earlier, followed by Technology.

  • KPCB XV Associates's ten largest holdings make up 100% of its $127M portfolio in Q4 2021.
  • KPCB XV Associates opened 0 new positions and closed 0 in Q4 2021.
  • KPCB XV Associates's portfolio value fell 5.3% quarter-over-quarter to $127M.

Based on KPCB XV Associates's 13F filing for Q4 2021, filed 14 Feb 2022.